-
-
The simultaneously obtained lead II and lead V1 rhythm strip seen above was interpreted as showing atrial fibrillation with a rapid ventricular response. Do you agree?
-
The ACCORD trial has been newsworthy in the last several months primarily due to the early results of increased cardiovascular events associated with very tight glucose control.
-
Everolimus is the newest oral kinase inhibitor approved for the treatment of advanced renal cell carcinoma.
-
Almost one-fifth of Medicare patients who were discharged from a hospital were rehospitalized within 30 days, and about a third were rehospitalized within 90 days. Most of these readmissions were not planned.
-
We don't have the slightest idea whether evidence of gallbladder dyskinesia should warrant cholecystectomy or not.
-
Once-a-week rosuvastatin therapy was well tolerated in patients with a history of adverse events to one or more statins and led to significantly improved lipoprotein changes.
-
The need for participation of the primary care physician in the treatment of sleep apnea has become much more apparent in recent years.
-
-
Aspirin dose and cardioprotection; uncovering modafinil's abuse potential; proton-pump inhibitors and clopidogrel; FDA actions.